FDA says to stop taking weight loss pill after finding it can cause cancer

(By Maia Anderson for Becker’s Hospital Review)

Eisai, a Japan-based drugmaker, said Feb. 13 it will remove its drug, Belviq, from the U.S. market after the FDA found an increased risk of cancer in people who took the weight loss drug.   Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.

Leave a Reply